Bruce F Bell
Examiner (ID: 11075)
Most Active Art Unit | 1741 |
Art Unit(s) | 1741, 1754, 1746, 1745, 2734, 1795, 1759, 1102 |
Total Applications | 2788 |
Issued Applications | 2338 |
Pending Applications | 153 |
Abandoned Applications | 297 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11767819
[patent_doc_number] => 09376394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-28
[patent_title] => 'Preparation of bendamustine and its salts'
[patent_app_type] => utility
[patent_app_number] => 13/517908
[patent_app_country] => US
[patent_app_date] => 2010-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6908
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13517908
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/517908 | Preparation of bendamustine and its salts | Dec 21, 2010 | Issued |
Array
(
[id] => 6039506
[patent_doc_number] => 20110092555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'Thiazolidinedione compound'
[patent_app_type] => utility
[patent_app_number] => 12/928525
[patent_app_country] => US
[patent_app_date] => 2010-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11362
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20110092555.pdf
[firstpage_image] =>[orig_patent_app_number] => 12928525
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/928525 | Thiazolidinedione compound | Dec 13, 2010 | Abandoned |
Array
(
[id] => 8760307
[patent_doc_number] => 08420827
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-16
[patent_title] => 'Thiazole derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/960937
[patent_app_country] => US
[patent_app_date] => 2010-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 136694
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12960937
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/960937 | Thiazole derivatives | Dec 5, 2010 | Issued |
Array
(
[id] => 6122038
[patent_doc_number] => 20110077399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'Substituted Azole Derivatives as Therapeutic Agents'
[patent_app_type] => utility
[patent_app_number] => 12/958237
[patent_app_country] => US
[patent_app_date] => 2010-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82547
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20110077399.pdf
[firstpage_image] =>[orig_patent_app_number] => 12958237
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/958237 | Substituted Azole Derivatives as Therapeutic Agents | Nov 30, 2010 | Abandoned |
Array
(
[id] => 10882717
[patent_doc_number] => 08907098
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-09
[patent_title] => 'Inhibitors of sphingosine kinase'
[patent_app_type] => utility
[patent_app_number] => 13/516370
[patent_app_country] => US
[patent_app_date] => 2010-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62414
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516370
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/516370 | Inhibitors of sphingosine kinase | Nov 17, 2010 | Issued |
Array
(
[id] => 9427884
[patent_doc_number] => 08703961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'Thiazole derivatives for the treatment of diseases such as cancer'
[patent_app_type] => utility
[patent_app_number] => 13/515537
[patent_app_country] => US
[patent_app_date] => 2010-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26109
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515537
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/515537 | Thiazole derivatives for the treatment of diseases such as cancer | Nov 8, 2010 | Issued |
Array
(
[id] => 8417684
[patent_doc_number] => 20120245185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'ARYL AND HETEROARYL SULFONES AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 13/508535
[patent_app_country] => US
[patent_app_date] => 2010-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30966
[patent_no_of_claims] => 99
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508535
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/508535 | Aryl and heteroaryl sulfones as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | Nov 7, 2010 | Issued |
Array
(
[id] => 7560816
[patent_doc_number] => 20110274648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-10
[patent_title] => 'Hepatitis C Virus Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/939778
[patent_app_country] => US
[patent_app_date] => 2010-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 210699
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20110274648.pdf
[firstpage_image] =>[orig_patent_app_number] => 12939778
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/939778 | Hepatitis C Virus Inhibitors | Nov 3, 2010 | Abandoned |
Array
(
[id] => 8359694
[patent_doc_number] => 20120214854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-23
[patent_title] => 'CARBOXY OXAZOLE OR THIAZOLE COMPOUNDS AS DGAT- 1 INHIBITORS USEFUL FOR THE TREATMENT OF OBESITY'
[patent_app_type] => utility
[patent_app_number] => 13/505917
[patent_app_country] => US
[patent_app_date] => 2010-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28114
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505917
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/505917 | Carboxy oxazole or thiazole compounds as DGAT-1 inhibitors useful for the treatment of obesity | Oct 31, 2010 | Issued |
Array
(
[id] => 9589580
[patent_doc_number] => 08779120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-15
[patent_title] => 'Macrocyclic derivatives of glycolurils, and methods of preparing and using the same'
[patent_app_type] => utility
[patent_app_number] => 13/265432
[patent_app_country] => US
[patent_app_date] => 2010-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 7186
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13265432
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/265432 | Macrocyclic derivatives of glycolurils, and methods of preparing and using the same | Oct 25, 2010 | Issued |
Array
(
[id] => 6178018
[patent_doc_number] => 20110178126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/910744
[patent_app_country] => US
[patent_app_date] => 2010-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51784
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20110178126.pdf
[firstpage_image] =>[orig_patent_app_number] => 12910744
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/910744 | Pyrazolylbenzothiazole derivatives and their use as therapeutic agents | Oct 21, 2010 | Issued |
Array
(
[id] => 5954467
[patent_doc_number] => 20110034527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'NOVEL 2-AMINO BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS'
[patent_app_type] => utility
[patent_app_number] => 12/909362
[patent_app_country] => US
[patent_app_date] => 2010-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9155
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034527.pdf
[firstpage_image] =>[orig_patent_app_number] => 12909362
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/909362 | NOVEL 2-AMINO BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF SMALL-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS | Oct 20, 2010 | Abandoned |
Array
(
[id] => 6189996
[patent_doc_number] => 20110172280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'Substituted Benzimidazoles'
[patent_app_type] => utility
[patent_app_number] => 12/905835
[patent_app_country] => US
[patent_app_date] => 2010-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20185
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20110172280.pdf
[firstpage_image] =>[orig_patent_app_number] => 12905835
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/905835 | Substituted benzimidazoles | Oct 14, 2010 | Issued |
Array
(
[id] => 8876070
[patent_doc_number] => 08471036
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-25
[patent_title] => 'Rhodacyanine derivative and pharmaceutical composition for treating leishmaniasis'
[patent_app_type] => utility
[patent_app_number] => 13/501456
[patent_app_country] => US
[patent_app_date] => 2010-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5329
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13501456
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/501456 | Rhodacyanine derivative and pharmaceutical composition for treating leishmaniasis | Oct 5, 2010 | Issued |
Array
(
[id] => 8642856
[patent_doc_number] => 08367843
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-05
[patent_title] => 'Phenol derivative'
[patent_app_type] => utility
[patent_app_number] => 13/499190
[patent_app_country] => US
[patent_app_date] => 2010-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 38239
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13499190
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/499190 | Phenol derivative | Sep 28, 2010 | Issued |
Array
(
[id] => 5954448
[patent_doc_number] => 20110034525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'NONSEDATING ALPHA-2 AGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/878593
[patent_app_country] => US
[patent_app_date] => 2010-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10282
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034525.pdf
[firstpage_image] =>[orig_patent_app_number] => 12878593
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/878593 | Nonsedating α-2 agonists | Sep 8, 2010 | Issued |
Array
(
[id] => 6342971
[patent_doc_number] => 20100330021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'SUBSTITUTED (THIAZOL-2-YL)-AMIDE OR SULFONAMIDE AS GLYCOKINASE ACTIVATORS USEFUL IN THE TREATMENT OF TYPE 2 DIABETES'
[patent_app_type] => utility
[patent_app_number] => 12/875215
[patent_app_country] => US
[patent_app_date] => 2010-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11175
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0330/20100330021.pdf
[firstpage_image] =>[orig_patent_app_number] => 12875215
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/875215 | SUBSTITUTED (THIAZOL-2-YL)-AMIDE OR SULFONAMIDE AS GLYCOKINASE ACTIVATORS USEFUL IN THE TREATMENT OF TYPE 2 DIABETES | Sep 2, 2010 | Abandoned |
Array
(
[id] => 8577945
[patent_doc_number] => 08344155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-01
[patent_title] => 'Chemical compounds'
[patent_app_type] => utility
[patent_app_number] => 12/936545
[patent_app_country] => US
[patent_app_date] => 2010-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25569
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12936545
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/936545 | Chemical compounds | Aug 25, 2010 | Issued |
Array
(
[id] => 4629608
[patent_doc_number] => 08008503
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-30
[patent_title] => 'Methyl-benzimidazole derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/862823
[patent_app_country] => US
[patent_app_date] => 2010-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20947
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1066
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/008/08008503.pdf
[firstpage_image] =>[orig_patent_app_number] => 12862823
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/862823 | Methyl-benzimidazole derivatives | Aug 24, 2010 | Issued |
Array
(
[id] => 9086574
[patent_doc_number] => 08558003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-15
[patent_title] => 'Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer\'s disease and related disorders'
[patent_app_type] => utility
[patent_app_number] => 12/854625
[patent_app_country] => US
[patent_app_date] => 2010-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17579
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12854625
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/854625 | Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders | Aug 10, 2010 | Issued |